Clinical Trials Logo

Osteonecrosis Due to Drug clinical trials

View clinical trials related to Osteonecrosis Due to Drug.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06457776 Recruiting - Clinical trials for Osteonecrosis Due to Drugs, Jaw

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

Start date: January 1, 2021
Phase:
Study type: Observational

The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.